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Summary 
The role of CD8 §  T  cells in resistance to herpes simplex virus (HSV) was examined. After 
cutaneous inoculation, HSV spreads to the peripheral nervous system (PNS) where it replicates 
in ganglionic neurons. In normal mice, replication of virus in the PNS was rapidly terminated 
and evidence of neuronal destruction, assessed by a quantitative histological assay, was sparse. 
Clearance of infectious virus was impaired, and a strikingly high proportion of ganglionic neurons 
was killed, in mice treated with an antibody that depleted them of CD8 + T cells. These results 
suggest that CD8 + T  cells play an important role in maintaining the integrity of the sensory 
nervous system during primary infection with HSV.  Therefore, viral epitopes recognized by 
CD8 + T  cells and restricting class I major histocompatibility complex genes are, in principle, 
implicated as interacting genetic determinants of neurovirulence. 
fter inoculation of HSV into the skin,  virus replicates 
in epidermal cells and spreads rapidly along sensory nerve 
fibres to infect spinal ganglia of the peripheral nervous system 
(PNS) 1 (1).  On reaching the PNS,  HSV DNA  sequences 
may lie dormant (latent) in primary sensory neurons for long 
periods creating a reservoir from which infection may peri- 
odically reactivate (2).  Concurrent  with  establishment  of 
latency, a proportion of sensory neurons become productively 
infected, judged by recovery of infectious virus from ganglia 
and the presence of viral antigens and nucleic acids in neurons 
(3, 4). Immunocompetent hosts rapidly control the produc- 
tive phase of herpes simplex but infection disseminates and 
becomes life threatening in neonates or when cellular immu- 
nity is impaired (5). Consequently, the immunological mech- 
anisms responsible for resolution of primary herpes simplex 
have received a great deal of attention. 
Several lines of evidence suggest that CD8 § T  lympho- 
cytes may play an important role in controlling HSV infec- 
tion. First,  class I MHC genes, the function of which are 
to restrict the activity of CD8 + cells (6), have a substantial 
influence on the severity of herpes simplex (7).  Second, in 
line with the classic paradigm that viral infections are con- 
trolled by cytotoxic T  lymphocytes, class I-restricted CTL 
can be recovered from lymph nodes draining herpetic lesions 
as early as 4 d after infection (8).  Finally,  adoptive transfer 
1 Abbreviation used in this paper: PNS,  peripheral  nervous  system. 
of draining lymph node cells enriched for CD8 + lympho- 
cytes can protect syngeneic recipients against potentially le- 
thal herpes if administered before or soon after inoculation 
of virus (9).  However, the efficacy of adoptively transferred 
cells is lost if their administration is delayed until 48 h after 
infection (9), and consequently, although CD8 + cells have 
an established immunoprophylactic role, their contribution 
towards recovery from infection is an issue that has not been 
satisfactory resolved. 
Experimental immunosuppression is commonly used for 
studying adaptive immunity and the use of mAbs to selec- 
tively deplete mice of lymphocyte subsets in vivo is a refine- 
ment of this approach (10). In the experiments reported here, 
a well-characterized anti-CD8 mAb, YTS 169.4 (10), shown 
previously to deplete mice of CD8 + lymphocytes and ablate 
HSV-specific  cytotoxicity (11), was used to selectively im- 
munosuppress mice before infection with HSV.  Using this 
strategy, it is shown that CD8 + cells make a substantial  con- 
tribution to the clearance of HSV from PNS tissues.  Fur- 
thermore, it is demonstrated that CD8 + cells contribute to 
the control of cutaneous infection in  H-2  d but  not  H-2 k 
mice. Therefore, H-2-1inked genes influence the overall con- 
tribution made by CD8 § cells in vivo, despite the potential 
complexity of antigenic challenge with HSV. 
We reasoned that classic H-2-restricted cytotoxicity cannot, 
on theoretical grounds, explain the activity of CD8 § cells 
in ganglia. In the experimental system used for this study, 
HSV infection in the PNS is largely confined to neurons (4), 
which unlike epidermal cells do not express MHC antigens 
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been suggested that  primary  sensory neurons may be able 
to survive an abortive infection with HSV (14).  Implicit in 
this suggestion is that the host's immune response does not 
destroy infected neurons, and this issue was directly addressed 
using a quantitative histological and histochemical approach. 
It is shown that the number of viral antigen-positive neurons 
in spinal ganglia at the peak of infection is significantly  greater 
than subsequent neuronal loss, supporting the concept of abor- 
tive HSV replication in neurons of immunocompetent hosts. 
However, in  mice depleted of CD8 + T  cells,  a strikingly 
high proportion of ganglionic neurons are destroyed. Thus, 
neuronal survival depends on adequate recognition of infec- 
tion by CD8 + lymphocytes, raising the novel concept that 
T cell epitopes on viral proteins, together with host immune 
response genes,  may function  as interacting  genetic deter- 
minants  of viral neurovirulence. 
Materials and Methods 
Virus Strain.  A well-characterized isolate of HSV type 1, strain 
SC16 (15), was used. This virus, which is neuroinvasive in mice 
(16), was grown and titrated in vero cells (17) and stored at -70~ 
until required. 
Infection of Mice.  Adult female BALB/c (H-2a), CBA (H-2k), 
A/J (H-2k/a), B10.D2 (H-2a), and B10.Br (H-2  k) mice were ob- 
tained from the specific pathogen-free  facility (Animal Resource 
Centre,  Perth, Western Australia). The zosteriform model used in 
all experiments  has been described in detail elsewhere (16, 18). 
Briefly, after depilation with Nair (Carter-Wallace, NSW, Australia), 
a small patch of skin on the left flank, innervated by the eighth 
through tenth thoracic dorsal root ganglia (T8-T10), was scarified 
with a 27-gauge needle through a 10-#1 drop of virus suspension 
containing  5  x  104 PFU. 
Titration of Virus in Tissue Samples.  Skin  samples and left tho- 
racic dorsal root ganglia were removed as described previously (18) 
and stored at  -70~  until required. Unless otherwise indicated, 
pooled ganglia spanning the sixth through thirteenth  thoracic seg- 
ments of each experimental animal were examined. Tissues were 
homogenized  in 1-ml glass tissue grinders (Wheaton Industries, 
Millville, NJ) and 10-fold dilutions of the homogenates were tested 
for presence of infectious virus using vero cells in a standard plaque 
assay (17). 
In Vivo Depletion of CD8 § Cells.  Hybridoma YTS 169.4 (10), 
screening rat IgG2b anti-Lyt-2.1, was grown in pristane-primed 
(LOU/M  x  DA)F1 rats (Animal Resource Centre).  Dialyzed as- 
cites, containing  1 mg/ml active antibody, were stored at  -70~ 
until required. The short duration  of the experimental infection 
(8 d) enabled euthymic mice to be depleted of CD8 + cells by in- 
fusion of I mg of antibody 4 d before infection and again 1 and 
5 d  after infection.  Control mice received PBS. Depletion  was 
confirmed by immunohistochemical analysis of spleens removed from 
the experimental animals postmortem. Frozen sections (6 gin) were 
reacted sequentially with YTS 169.4, peroxidase-conjugated goat 
f(ab')2 anti-rat  IgG (Tago Inc.,  Burlingame,  CA)  and 3,3'-dia- 
minobenzidine  (0.5 mg/ml containing  0.1%  H202). Slides were 
washed (10 rain) in tris buffer (pH 7.4) between steps. 
Immunohistochemical Detection of Viral Antigens.  Primary anti- 
bodies were: (a) rabbit antiserum to HSV-infected cells (Dakopatts, 
Glostrup, Denmark),  and (b) mAb LP1 (19) to virion polypeptide 
16 (VP16). Binding of primary antisera was detected using swine 
anti-rabbit or goat anti-mouse Ig as appropriate, followed by rabbit 
or mouse peroxidase antiperoxidase conjugate, respectively  (all from 
Dakopatts).  All reactions were allowed to proceed for 30 rain at 
37~  with two 5-rain washes in 50 mM Tris buffer (pH 7.4) be- 
tween each step. Bound antibody was detected using 3,Y-diamino- 
benzidine (0.5 mg/ml, containing 0.1% H202), and sections were 
lightly counterstained  with hematoxylin. 
Enumeration of Neuronal Profiles.  The strategy for comparing 
the neuronal content of spinal ganglia was based on precise deter- 
mination  of the mean number of neuronal profiles visualized in 
5-gm paraffin sections. Dorsal root ganglia (T10) were removed 
and fixed immediately in periodate-lysine-paraformaldehyde (PLP) 
for 60 min (20) and then transferred to 50% ethanol. Pooled samples 
from groups of 30 mice were rolled into a ball, paraffin embedded, 
and  5-gm sections were collected onto glutaraldehyde-activated 
3-aminopropyltriethoxysilane-coated  slides. Sections were stained 
with hematoxylin and eosin (H&E), and profiles with the charac- 
teristic appearance of primary  sensory neurons were enumerated 
(x 156)using a l-ram graticule (519-950; E. Leitz Inc., Kockleigh, 
NJ). A similar strategy was applied to immunohistologically stained 
sections for enumeration  of antigen-positive  (Ag §  neurons. 
Results and Discussion 
Treatment with Anti-CD8 Impairs Virus Clearance.  In mice, 
as in humans, the recovery phase of primary herpes simplex 
typically spans the period 6-10 d after infection (1).  In the 
experiments reported here, the effect of selective T cell subset 
depletion on clearance of virus from skin and PNS tissue of 
groups of 5-10 mice was studied 8 d after infection. Com- 
pared with controls, significantly more infectious virus (typi- 
cally ~ol00-fold) was recovered from spinal ganglia (T6-T13) 
of CD8-depleted mice of all strains tested (Fig. 1), whereas, 
in the same animals, impaired control of cutaneous infection 
was mouse strain dependent (Fig. 2). Treatment with anti- 
CD8 increased virus yield 50-fold from the skin of BALB/c 
(H-2K'rD  a) animals  (p <0.01), whereas CBA (H-2KkD  k) and 
A/J (H-2KkD  d) mice were unaffected.  The behavior of the 
antibody-treated H-2  ~ strains cannot be explained by inade- 
quate depletion of CD8 + cells because virus clearance from 
their PNS tissues was substantially impaired.  Additionally, 
CD8 + cells could not be detected immunohistochemically 
in the spleens of mAb-treated H-2  k animals  (Fig.  3). There- 
fore,  it  is  likely  that,  in  association  with  H-2  k (or  more 
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specifically  H-2K  k) gene products,  CD8 + lymphocytes do 
not make a significant contribution to virus clearance from 
the skin, despite the potentially complex nature of antigenic 
challenge with  HSV.  Evidence for an association between 
H-2-1inked genes and the observed differences in mouse strain 
behavior was strengthened by examining H-2 congenic mice. 
Anti-CD8 markedly compromised B10.D2  (H-2  d) animals, 
but B10.Br  (H-2  k) mice were unaffected (Fig.  2). 
CD8 + Cells  Limit  the Spread  of HSV  in  the PNS.  The 
contribution made by CD8 + cells in controlling HSV in- 
fection in the PNS was investigated further, by enumerating 
Ag  + neurons in ganglia of normal and CDS-depleted  BALB/c 
mice 8 d  after infection (Fig.  4).  To measure the extent of 
the viral spread to spinal ganglia not directly innervating the 
site of  cutaneous inoculation, individual spinal segments (sixth 
thoracic through first lumbar) were separately analyzed (Fig. 
5).  As expected, very few infected neurons were identified 
immunohistochemicaUy  in immunocompetent mice, concor- 
dant with almost complete recovery by day 8.  In contrast, 
in  mice  selectively  depleted  of  CD8 §  cells,  a  striking 
number of Ag  § profiles were present at all spinal levels ex- 
amined. 
Fate of  HSV-infected Neurons.  The results presented in this 
section pertain to ganglia of the tenth thoracic (T10) neu- 
rodermatome, upon which acute infection is centered in the 
model system described. In H&E-stained sections, primary 
sensory neurons are readily identified owing to their large 
size and characteristic appearance (Fig.  6, a  and b) and cell 
profile counting was facilitated by use of a l-ram graticule. 
Despite the presence of a mononuclear inflammatory infiltrate 
surrounding many neurons in acutely infected ganglia (Fig. 
6 c), neuronal architecture was well preserved and cells stained 
with polyclonal antiserum were normal in size, showed no 
obvious evidence of nuclear or nucleolar breakdown, and were 
not fused to surrounding support cells (Fig. 6 d). These ob- 
servations suggested that neurons differ from cultured cells 
and epidermal cells in their response to HSV.  Therefore, a 
quantitative histological approach was used to measure directly 
the extent of neuronal destruction caused by HSV infection 
in BALB/c ganglia. 60 animals were infected (day 0) on the 
left flank and 30 were killed at  the peak of infection (day 
5) for immunohistochemical studies. The remaining 30 mice 
were killed after recovery (day 8),  for enumeration of T10 
sensory neurons. For comparison, ganglia were removed from 
Figure  3.  Immunohistochemical 
staining  of  splenic  sections  for 
CD8 +  cells. (a)  Typical distribu- 
tion  of CD8 + cells  (black)  in  an 
immunocompetent  CBA mouse. (b) 
Representative  example  of CD8 + 
cell depletion  in an infected CBA 
mouse,  after a course of treatment 
with mAb YTS169.4. 
1339  Simmons  and  Tscharke Figure 4.  Immunohistochemical  detection of HSV antigens in BALB/c T10 ganglia 8 d after infection. (a) Typical section from a normal mouse, 
and (b) widespread infection characteristic of animals treated with anti-CD8. Sections were lightly counterstained with hematoxylin and photographed 
using a BG38 red suppression filter (E. Leitz, Inc.) to enhance contrast between antigen-positive cells (dark areas) and uninfected cells (pale areas). 
two groups of 30 uninfected mice. Paraffin blocks, prepared 
from the pooled T10 ganglia of each group of animals, yielded 
in total •200  slides. A large number (>30) of the slides from 
each block were randomly selected for analysis. The number 
of individual ganglionic sections on each chosen slide ranged 
from 10 through 21, and in total, the actual number of gan- 
glionic sections examined for each experimental group ranged 
from 434 through 672.  No attempt was made to determine 
the absolute number of neurons present in ganglia because 
there is dispute regarding the correction factors that must 
be applied to profile counts in order to generate this infor- 
mation (21). Instead, the mean number of neuronal profiles 
per ganglionic section was used as the basis for comparison 
between the experimental groups, on the premise that this 
value is related to the absolute number of neurons present 
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Figure 5.  Mean number of Ag + neuronal profiles/ganglionic section 
(T6-LI) 8 d after infection in immunocompetent  vs CD8 + cell-depleted 
mice. Innervation  of the cutaneous inoculation site is provided predomi- 
nantly by T8-T10. 
in a ganglion, irrespective of cell density. Comparative data 
were sufficient for the purpose of this study. 
At the peak of infection, a mean of 18.7 neuronal profiles/ 
ganglionic section were antigen positive, using polyclonal an- 
tiserum to HSV-infected cells (Fig.  7 a). Neuronal infection 
was further characterized using a mAb to the HSV late gene 
product VP16, expression of which signifies an advanced stage 
of  viral replication (22). On average, 12.7 neuronal profilesAec- 
tion were VP16 +, most of which showed no gross abnor- 
malities of architecture (Fig. 7 b). On day 8, antigen had been 
cleared and comparison with uninfected tissues disclosed only 
a small dropout of neuronal profiles (4.7/section) (Table 1, 
exp. 1). It was concluded, subject to a detailed statistical analysis 
of these data,  that the number of Ag + neurons present in 
T10 ganglia at the peak of infection exceeds the number of 
neurons destroyed. 
Statistical  Analysis.  Each histological slide,  containing a 
minimum of 10 and a maximum of 21 individual ganglionic 
sections, was used to make an independent estimate of the 
number of neuronal profiles/section (total profiles counted 
divided by the number of ganglia on the slide).  It was as- 
sumed that these estimates were normally distributed about 
the true population  mean, based on  the large number of 
samples (>30) taken from each block.  In exp.  1,  the mean 
number of neurons in ganglia of normal (uninfected) mice 
and animals that had recovered from infection were compared 
by calculating the difference between means and its SE (4.7 
_+ 2.0), using standard formulae. Because the difference be- 
tween the means exceeds twice the SE, the null hypothesis, 
i.e., that there is no difference in numbers of neurons before 
and after HSV infection, can be rejected (95% confidence). 
Therefore, it was concluded that some neurons were killed 
by HSV infection in this experiment. 
The question next addressed is whether destruction of all 
the Ag + neurons present on day 5 is compatible with the 
observed  neuronal  dropout.  Stringent  confidence  levels 
(99.75%; i.e.,  •  3 SEM) were set for this analysis. The mean 
1340  Anti-CD8 Impairs Clearance of HSV from the Nervous  System Figure 6.  Histological  and immunohistochemical  analysis  ofT10 ganglia  removed  from BALB/c  mice  before, or 5 d after, infecting  skin of the midflank 
with 5  ￿  104 PFU HSV-1, strain SC16. (a) H&E-stained uninfected ganglion (￿  showing primary sensory neurons  (large, rounded cells) sur- 
rounded by much smaller  capsular cells (visible at this magnification  only by their darkly staining nuclei). (b) H&E-stained primary sensory  neurons 
(￿  are readily identified  by their large size, characteristic nucleic acid-rich cytoplasm, and ovate nucleus with one or more prominent nucleoli. 
Surrounding  capsular  cells have  little or no visible  cytoplasm.  (c) Inflammatory  response  (￿  156) typically  seen  at the peak of  infection  (day  5). Mononuclear 
cells infiltrate the oedematous  ganglion, sometimes surrounding and partially obscuring individual  neurons and there is also a prominent subcapsular 
infiltrate.  The neurons  themselves  are intact. (d) Morphologically  preserved  antigen-positive  neuron  (darkly  staining  cell),  demonstrated  immunohistochemically 
using polyclonal  antiserum directed against HSV-infected  cells. 
dropout  of 4.7  +  2.0 profiles/section was compared with 
18.7  _+  0.7  Ag +  profiles  on  day 5,  and  in  this  case,  the 
difference between  the means is  14  +  2.2.  The  difference 
greatly exceeds 3 SE, and on this basis we reject the hypoth- 
esis (99.75%  confidence level) that all Ag §  neurons are de- 
stroyed. On day 5, 12.7  _+  1.6 neuronal profiles/section were 
VP16 +, compared with a mean loss after recovery 4.7  +  2. 
The difference between the means is 8  +  2.56. Because the 
difference exceeds  3  SEM,  the  hypothesis  that  all  VP16 + 
neurons  are destroyed was  rejected. 
Treatment with Anti-CD8 Increases Neuronal Destruction.  In 
view of the florid PNS infection experienced by CD8-deficient 
mice, ganglia removed from 30 immunocompetent and 30 
CD8-depleted animals were compared with respect to neu- 
ronal dropout,  8 d  after infection (Table  1,  exp.  2).  In this 
experiment, dropout was insignificant in the immunocompe- 
tent control group (0.6  +  3.2 profiles/section). In contrast, 
loss of neurons was strikingly high in mice treated with anti- 
CD8  (50.6  profiles/section unaccounted for).  As expected, 
selective depletion of CD8 § cells prevented normal clearance 
of viral antigen.  It was concluded that depletion of CD8 + 
T lymphocytes increases the level of neuronal destruction as- 
sociated with the acute phase of HSV  infection. 
Discussion and Implications.  The mechanism of action of 
herpes-specific CD8 + cells in vivo remains an area of specu- 
lation. It has been proposed that cells with cytotoxic activity 
contribute to virus clearance from cutaneous lesions (23). In 
vitro, class I-restricted CTL preferentially recognize HSV an- 
tigens in association with H-2K (rather than H-2D)  alleles 
(24),  and in the experimental system described here, MHC 
restriction  of CD8 +  cells  in  vivo was  similarly associated 
with H-2K. This circumstantially links class I-restricted CTL 
activity  with  antiviral  immunity.  However,  CBA  (H-2  k) 
mice ultimately clear infectious virus from cutaneous lesions, 
apparently without the assistance of CD8 + cells (11). There- 
fore, it is likely that other responses, such as class II-restricted 
cytotoxicity (28)  or DTH  (29),  are of primary importance 
in the resolution of cutaneous lesions. In support of this hy- 
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the skin (11) and cutaneous lesions fail to resolve in CD4 + 
cell-deficient  AIDS patients  (5). 
Treatment with anti-CD8 had a profound influence on the 
severity  of PNS  infection.  In CD8-deficient  mice,  a  high 
proportion of HSV-infected ganglionic neurons were killed, 
and  neural  spread  of virus  was  enhanced,  suggesting  that 
CD8 + T  cells play an important role in maintaining the in- 
tegrity of the sensory nervous system during infection with 
Figure 7.  lmmunohistochemical 
analysis of spinal ganglia  from HSV- 
infected mice. (a) Typical number 
of Ag  + neuronal profiles/ganglionic 
section seen in a BALB/c ganglion 
(x156)  removed at  the  peak of 
infection (day 5) and stained with 
polyclonal  antiserum directed  against 
HSV-infected cells. The  section, 
lightly counterstained with bema- 
toxylin, was photographed using a 
BG38  red  suppression filter (E. 
Leitz, Inc.) to enhance contrast be- 
tween antigen-positive cells (black) 
and uninfected  cells (pale). Antigen 
was largely  confined  to neuronal so- 
mata and their axons (the latter are 
seen in cross-section  at the bottom). 
(b)  Preserved cellular architecture 
(x 500) of neurons expressing cyto- 
plasmic and nuclear VPI6, an HSV 
late gene. 
HSV. In principle, these results implicate T  cell epitopes on 
viral proteins,  together with restricting  host  MHC genes, 
as potentially interacting determinants of neurovirulence.  It 
has been shown that viruses might escape immune surveil- 
lance  by  mutation  of epitopes  recognized  by  CD8 §  cells 
(25), raising the novel possibility that neurovirulence might 
spontaneously be enhanced as  a result  of selective pressure 
by the immune  response. 
Three mechanisms can be envisaged by which CD8 + cells 
Table  1.  Fate of HSV-infected  Neurons  in  Normal and Anti-CD8-treated  BALB/c  Mice 
Exp. 
Mean neuronal profiles  (~)  per  ganglionic section  +.  SEM* 
Normal mice (exps.  1 and 2)  Anti-CD8 treated  (exp.  2 only) 
Uninfected - total  139.4  +_  1.6  (~1)  -* 
Day 8  - total  :  1  134.7  _+  1.2  (~2) 
:  2  138.8  +_  2.8  (~3)  88.8  +,  3.3  (~4) 
Day 8 - loss  :  1  4.7  +,  2.0  (~1-~2) 
:  2  0.6  +_  3.2  (~a-~3)  50.6  +,  3.7  (~1-~4) 
Day 8 - Ag  +  :  1  0 
:  2  0  12.7  •  4.5 
Day 5 -  Ag §  :  1  18.7  +.  0.7 
Day 5- VP16 +  '  1  12.8  +,  1.6 
* The number of sections/slide ranged from 10 through 21, and >30 slides from each histological block were examined in all cases. The total number 
of neuronal profiles counted from each group of animals ranged from m60,000 through  94,000. 
* It was assumed that  treatment with  anti-CD8 did not alter the number of primary sensory neurons in ganglia of uninfected mice. 
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CTL might limit the spread of virus and hence the ultimate 
amount of damage, by rapidly killing infected neurons;  (b) 
cytokine release might protect uninfected neurons, thus lim- 
iting the spread of infection; and (c) CD8 § cells might pro- 
mote, directly or indirectly, termination of viral gene expres- 
sion  in  neurons  without  inducing  cytolysis,  perhaps  by 
releasing cytokines that interfere with multiple stages of the 
viral replicative cycle, as described in other systems (26-28). 
In spinal  ganglia, it is unlikely that HSV-specific CD8 + cells 
mediate their antiviral effect by direct cytotoxicity, irrespec- 
tive of their mode of action in the skin. It has been proposed 
that lack of MHC expression protects neurons against attack 
by CTL (29),  allowing viral infection to be terminated  by 
nonlytic mechanisms (30). The results presented here are con- 
sistent with this hypothesis, because in normal  animals we 
were unable to prove that all HSV antigen-positive neurons 
are killed. Therefore, we favor a nonlytic role for CD8 § cells 
in  the  PNS.  Whatever  their  mechanism  of action,  CD8 + 
cells must be stimulated  in  the PNS by antigen  presented 
in the context of class I MHC molecules, and capsular cells, 
which surround  each ganglionic neuron,  might  fulfill  this 
function.  Capsular cells are counterparts of CNS microglia 
and, though not productively infected themselves (31), they 
strongly express MHC glycoproteins during the acute phase 
of herpes  simplex  (13). 
Replication of HSV DNA is dependent  on synthesis of 
numerous virally encoded polypeptides (22). In contrast, es- 
tablishment of latency is not dependent on viral gene expres- 
sion (4, 32), implying that HSV DNA replication is not a 
prerequisite for persistence of viral genomes in the PNS. How- 
ever, a strikingly large amount of viral DNA can be recov- 
ered from latently infected tissue (33), and, in spinal ganglia 
of mice, two patterns of persistence of HSV DNA sequences 
have recently been distinguished, on the basis of location and 
number  of viral  genome equivalents per cell  (34).  Conse- 
quently,  there  may be more  than  one molecular  pathway 
leading to latency.  It remains to be shown whether abortive 
infection is responsible for most of the viral sequences that 
persist in the nervous system, but it is attractive to speculate 
that a unique interaction between neurons and HSV may have 
coevolved with the host's ability to protect infected neurons 
from CTL. Latency conveys an enormous survival advantage 
to viruses (35), and preservation of vitally infected neurons 
might be regarded as an evolutionary compromise that favors 
both virus and host. 
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